LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Entrada Therapeutics (NASDAQ: TRDA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
06/27/2025
Sell
$6.91
55,735
$385K
3.22M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
06/30/2025
Sell
$6.81
18,578
$127K
3.20M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
07/01/2025
Sell
$7.12
18,578
$132K
3.18M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
06/27/2025
Sell
$6.91
19,265
$133K
1.11M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
06/30/2025
Sell
$6.81
6,422
$44K
1.11M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
07/01/2025
Sell
$7.12
6,422
$46K
1.10M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
06/27/2025
Sell
$6.91
55,735
$385K
3.22M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
06/30/2025
Sell
$6.81
18,578
$127K
3.20M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
07/01/2025
Sell
$7.12
18,578
$132K
3.18M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
06/27/2025
Sell
$6.91
19,265
$133K
1.11M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
06/30/2025
Sell
$6.81
6,422
$44K
1.11M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
07/01/2025
Sell
$7.12
6,422
$46K
1.10M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
06/11/2025
Buy
$7.90
19,000
$150K
19,000
NASDAQ TRDA Entrada Therapeutics
KIM PETER S / director
06/11/2025
Buy
$7.90
19,000
$150K
19,000
NASDAQ TRDA Entrada Therapeutics
Thistle Mary / director
06/11/2025
Buy
$7.90
19,000
$150K
19,000
NASDAQ TRDA Entrada Therapeutics
Zeiher Bernhardt G / director
06/11/2025
Buy
$7.90
19,000
$150K
19,000
NASDAQ TRDA Entrada Therapeutics
Chapman Gina / director
06/11/2025
Buy
$7.90
19,000
$150K
19,000
NASDAQ TRDA Entrada Therapeutics
Radhakrishnan Maha / director
06/01/2025
Buy
$7.60
38,000
$289K
38,000